ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare

NEW YORK and NIJMEGEN, Netherlands, Dec. 1, 2025 /PRNewswire/ -- ScreenPoint Medical today announced the completion of a commercial agreement making its Transpara® breast-imaging AI portfolio available through Precision Imaging Network, part of Microsoft for Healthcare. By integrating Transpara with Precision Imaging Network , ScreenPoint Medical expands how healthcare providers can access Breast AI tools to support workflow efficiency and clinical decision-making.

ScreenPoint Medical selected Precision Imaging Network to help strengthen the scalability and integration options for the Transpara Breast AI portfolio across mammography and related breast imaging modalities. Leveraging Precision Imaging Network allows ScreenPoint Medical to simplify deployment pathways for healthcare organizations seeking cloud-enabled access to Breast AI tools within existing clinical ecosystems.

Enhancing Access to Breast AI at Scale

ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence, and breast cancer detection. The most clinically validated Breast AI on the market, Transpara provides radiologists with a ‘second pair’ of eyes to help detect cancers earlier and reduce reading workload. Making the Transpara portfolio available through Precision Imaging Network  streamlines integration, offering healthcare providers a secure and standardized connection point to initiate and manage clinical AI capabilities.

Sign up for Blog Updates